Search

Your search keyword '"Bayne, M."' showing total 295 results

Search Constraints

Start Over You searched for: Author "Bayne, M." Remove constraint Author: "Bayne, M."
295 results on '"Bayne, M."'

Search Results

1. Service Improvements and Workload Increases: Royal College of Radiologists (RCR) Re-Audit of Curative Intent Radiotherapy for Non-Small Cell Lung Cancer (NSCLC)

2. Reimagining Transcultural Identity: A Case Study of Field Experiences for International Preservice Teachers

5. Service improvements and workload increases; Royal College of Radiologists (RCR) re-audit of curative intent radiotherapy for non-small cell lung cancer (NSCLC)

6. Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial

7. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study*

12. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study

13. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study

14. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study

15. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study

16. Dahlias and gladiolus : 1928 [price list] /

17. Dahlias and gladiolus : 1927 [price list] /

18. Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*

22. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study

23. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study

24. 样肉芽肿和 Sézary 综合征患者生活质量研究

25. A study of quality of life in people with mycosis fungoides and Sézary syndrome

28. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study

29. Implications for UK practice of the use of durvalumab in stage III NSCLC

31. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients

33. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study

34. The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

42. LYMRIT 37-01: UPDATED RESULTS OF A PHASE I/II STUDY OF 177 LU-LILOTOMAB SATETRAXETAN, A NOVEL CD37-TARGETED ANTIBODY- RADIONUCLIDE-CONJUGATE IN RELAPSED NHL PATIENTS

44. 107 - An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study

Catalog

Books, media, physical & digital resources